Table 2.
M. genitalium (MG) positivity by gender and body site.
| All Body Sites | ||||
|---|---|---|---|---|
| Result | Urogenital | Oral | Anal | Total |
| Positive | 22 (9.5%) | 2 (0.9%) | 9 (4.4%) | 33 (5.0%) |
| Total | 232 (100%) | 228 (100%) | 206 (100%) | 666 (100%) |
| Females | ||||
| Result | Urogenital | Oral | Anal | Total |
| Positive | 12 (10.3%) | 0 (0%) | 7 (6.7%) | 15 (4.5%) |
| Total | 116 (100%) | 114 (100%) | 105 (100%) | 335 (100%) |
| Males | ||||
| Result | Urogenital | Oral | Anal | Total |
| Positivea | 10 (8.6%) | 2 (1.8%) | 2 (2.0%) | 13 (3.9%) |
| Total | 116 (100%) | 114 (100%) | 101 (100%) | 331 (100%) |
Notes: M. genitalium was detected by MGMR PCR.
Column percentages are presented for each body site; therefore, those percentages will not sum to the total percentage.
a
Includes both wild-type and drug-resistant associated mutant Mycoplasma genitalium (MG)